Search research articles
Contact Us
Filters
Showing results (51-60 of 118) with videos related to
Page
of 12
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 3, 2022
HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer
Alexandra Samborski, M Craig Miller, Alexandra Blackman, et al.
Chemical Biology & Drug Design
|
October 7, 2011
Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells
Thilo S Lange, Timothy C Horan, Kyu K Kim, et al.
Gynecologic Oncology
|
March 18, 2014
Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone
Katina Robison, Dario Roque, Carolyn McCourt, et al.
Translational Oncology
|
May 15, 2019
Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer
Rachael B Rowswell-Turner, Jennifer A Rutishauser, Kyu Kwang Kim, et al.
Gynecologic Oncology
|
December 3, 2014
Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer
Richard G Moore, Douglas M Hawkins, M Craig Miller, et al.
Gynecologic Oncology
|
August 2, 2011
Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines
Laurent Brard, Thilo S Lange, Katina Robison, et al.
Gynecologic Oncology
|
May 23, 2008
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
Richard G Moore, Amy K Brown, M Craig Miller, et al.
Gynecologic Oncology
|
May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
Donna Badgwell, Zhen Lu, Laurence Cole, et al.
Frontiers in Oncology
|
February 7, 2018
Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer <i>via</i> Regulation of the Extracelluar Matrix
Jennifer R Ribeiro, Hilary M Gaudet, Mehreen Khan, et al.
Plos One
|
December 2, 2024
The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer
Kyukwang Kim, Negar Khazan, Jamie L McDowell, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 118) with videos related to
Sort By:
Page
of 12
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
October 3, 2022
HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer
Alexandra Samborski, M Craig Miller, Alexandra Blackman, et al.
Chemical Biology & Drug Design
|
October 7, 2011
Cytotoxic properties of Adamantyl isothiocyanate and potential in vivo metabolite adamantyl-N-acetylcystein in gynecological cancer cells
Thilo S Lange, Timothy C Horan, Kyu K Kim, et al.
Gynecologic Oncology
|
March 18, 2014
Long-term follow-up of vulvar cancer patients evaluated with sentinel lymph node biopsy alone
Katina Robison, Dario Roque, Carolyn McCourt, et al.
Translational Oncology
|
May 15, 2019
Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer
Rachael B Rowswell-Turner, Jennifer A Rutishauser, Kyu Kwang Kim, et al.
Gynecologic Oncology
|
December 3, 2014
Combining clinical assessment and the Risk of Ovarian Malignancy Algorithm for the prediction of ovarian cancer
Richard G Moore, Douglas M Hawkins, M Craig Miller, et al.
Gynecologic Oncology
|
August 2, 2011
Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines
Laurent Brard, Thilo S Lange, Katina Robison, et al.
Gynecologic Oncology
|
May 23, 2008
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
Richard G Moore, Amy K Brown, M Craig Miller, et al.
Gynecologic Oncology
|
May 29, 2007
Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment
Donna Badgwell, Zhen Lu, Laurence Cole, et al.
Frontiers in Oncology
|
February 7, 2018
Human Epididymis Protein 4 Promotes Events Associated with Metastatic Ovarian Cancer <i>via</i> Regulation of the Extracelluar Matrix
Jennifer R Ribeiro, Hilary M Gaudet, Mehreen Khan, et al.
Plos One
|
December 2, 2024
The NF-κB-HE4 axis: A novel regulator of HE4 secretion in ovarian cancer
Kyukwang Kim, Negar Khazan, Jamie L McDowell, et al.
Page
of 12